Breaking News

GC Biopharma Receives WHO Pre-Qualification for Fil-Finish Plant

The plant has state-of-the-art automation facilities that automates the entire process from raw material warehousing to production and shipment.

GC Biopharma, a provider of biopharmaceutical products, said that the World Health Organization (WHO) awarded prequalification for its fill-finish plant in Ochang, South Korea. “We hope to contribute to advancing global public health based on our know-how and manufacturing capabilities that have produced and supplied vaccines for half a century,” said EC Huh, president of GC Biopharma. The plant, established in 2019, is the largest fill-finish facility in South Korea, according...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters